Why GMO ETFs
Our exchange-traded funds (ETFs) offer a flexible way of investing in innovative GMO solutions, which are built on nearly 50 years of experience.
Active, TransparentActively managed with daily holdings transparency |
Tax-EfficientTax efficiency for U.S. taxable shareholders from fewer taxable events |
Access and ScalabilityNo minimum size required to invest in long-running GMO strategies |
Our Investment Philosophy
Highly specialized GMO investment teams are grounded in a common belief that a long-term, valuation-based approach will maximize risk-adjusted returns.
We are known for our willingness to challenge the status quo and the creative ways we approach investment problems.
These core philosophies power our singular drive to deliver outstanding long-term investment returns to our clients, including in our ETFs.
GMO ETF LineUp
We are committed to offering investment solutions in the implementation structures that best address investor needs. Our ETF suite offers access to several of GMO’s core investment capabilities where we see compelling opportunities today.
High-Quality Equity |
Value Equity |
Multi-Asset Class |
|||
 |
U.S. Quality ETF (QLTY) |  |
U.S. Value ETF (GMOV) |  |
Dynamic Allocation ETF (GMOD) |
 |
International Quality ETF (QLTI) |  |
International Value ETF (GMOI) | ||
Deglobalization |
Fixed Income |
||||
 |
Beyond China ETF (BCHI) |  |
Systematic Investment Grade Credit ETF (INVG) | ||
 |
Domestic Resilience ETF (DRES) |  |
Ultra-Short Income ETF (GMOC) | ||
Featured ETF
Dynamic Allocation ETF
For the first time, GMO’s Asset Allocation approach is available in an ETF.
Featured ETF
Ultra-Short Income ETF
Actively managed ETF targets current income while preserving capital through high-quality, short-duration fixed income securities.
ETF Research
 |
How A “Big Bet” Remains Poised for Future OutperformanceBy the Asset Allocation Team | April 2026International deep value remains attractively priced and is a high-conviction, active position across all GMO Asset Allocation portfolios. |
 |
Gains Without PainsBy the Asset Allocation Team | March 2026How GMO Dynamic Allocation (GMOD) helps with reallocating a balanced portfolio (without the tax drag). |
 |
Year-End Letter for 2025: Deep ValueBy John Thorndike, Warren Chiang and George Sakoulis | March 2026In this year-end letter, John Thorndike, Warren Chiang, and George Sakoulis discuss GMOV and GMOI results for 2025 and their outlook for 2026. |
 |
Navigating a Sea of Investment-Grade CreditBy James Donaldson, Rachna Ramachandran and Mina Tomovska | June 2025Why we believe using quantitative methods in a transparent, repeatable way to extract alpha through diversified factor tilts offers a compelling alternative in the new IG environment. |
 |
Quality: The Real McCoyBy Kim Mayer | October 2024Through market cycles and dislocations, high-quality equities have proven to be a stable group of exceptional businesses ideally suited to compounding capital. |
 |
GMO Quarterly Letter: The Quality AnomalyBy Ben Inker | 4Q 2023Contrary to portfolio theory, investors have historically been able to achieve both higher returns and lower risk by owning the highest quality stocks. |
